Generic placeholder image

Current Medical Imaging

Author(s): Mohammad Ishraq Zafar, Lu-Lu Chen, Ye Xiaofeng and Feng Gao*

DOI: 10.2174/1573405614666180806124416

DownloadDownload PDF Flyer Cite As
Impact of Diabetes Mellitus on Radiological Presentation of Pulmonary Tuberculosis in Otherwise Non-Immunocompromised Patients: A Systematic Review

Page: [543 - 554] Pages: 12

  • * (Excluding Mailing and Handling)

Abstract

Background: Studies on the influence of diabetes mellitus on the radiological presentation of pulmonary tuberculosis performed so far yielded inconsistent results. We aimed to summarize the relevant evidence on this topic systematically.

Methods: We systematically searched PubMed/MEDLINE (1980–2016) and the references of related articles (English-language reports) for observational studies that compared the radiological presentation of pulmonary tuberculosis in diabetes and non-diabetes patients.

Results: A total of fifteen studies that enrolled 2,020 diabetic patients and 5,280 controls were included in this systematic review. None of the included studies showed any significant difference in the upper lobe involvement and or in bilateral disease between diabetes and non-diabetes patients. However, lower lung field cavitary disease was found to be more frequent (relative risks ranging from 2.76, 95% CI 2.28-3.35 to 4.47, 95% CI 2.62-7.62) in patients with poor glycemic control (HbA1C >9%). Similarly, a significantly higher proportion of cavitary disease in diabetes patients was reported by 7 out of 15 studies, the meta-analysis of cavities of any size/site also showed the significantly higher risk of cavitary disease in diabetes patients (p-value = 0.0008). Three studies stratified the presence of cavities by diabetes control status, finding a higher proportion of cavities in uncontrolled diabetic patients (relative risks ranging from 1.85, 95%CI 1.34-2.55 to 3.59, 95%CI 2.53-5.11). One out of four studies found a significantly higher proportion of nodular infiltrations in diabetes versus non-diabetes patients.

Conclusion: While there is no difference in localization of lung lesions between patients with diabetes and non-diabetes, our review found that the risk of cavitary disease is relatively higher in diabetes patients. It is essential for researchers to unify the criteria for diabetes diagnosis, patient selection, and radiographic severity and stratify the results by the potentially confounding factors.

Keywords: Diabetes mellitus, hyperglycemia, mycobacterium infection, pulmonary tuberculosis, lesions, cavitary disease.

Graphical Abstract

[1]
Skowroński M, Zozulińska-Ziółkiewicz D, Barinow-Wojewódzki A. Tuberculosis and Diabetes Mellitus - an underappreciated association. Arch Med Sci 2014; 10(5): 1019-27.
[2]
Shaikh MA, Singla R, Khan NB, Sharif NS, Saigh MO. Does diabetes alter the radiological presentation of Pulmonary Tuberculosis. Saudi Med J 2003; 24(3): 278-81.
[3]
Wang CS, Yang CJ, Chen HC, et al. Impact of type 2 diabetes on manifestations and treatment outcome of Pulmonary Tuberculosis. Epidemiol Infect 2009; 137(2): 203-10.
[4]
Bacakoğlu F, Başoğlu OK, Cok G, Sayiner A, Ateş M. Pulmonary Tuberculosis in patients with Diabetes Mellitus. Respiration 2001; 68(6): 595-600.
[5]
Chiang CY, Lee JJ, Chien ST, et al. Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS One 2014; 9(4)e93397
[6]
Park SW, Shin JW, Kim JY, et al. The effect of diabetic control status on the clinical features of Pulmonary Tuberculosis. Eur J Clin Microbiol Infect Dis 2012; 31(7): 1305-10.
[7]
Swaminathan S, Narendran G, Menon PA, et al. Impact of HIV infection on radiographic features in patients with Pulmonary Tuberculosis. Indian J Chest Dis Allied Sci 2007; 49: 133-6.
[8]
Badie BM, Mostaan M, Izadi M, Alijani MAN, Rasoolinejad M. Comparing radiological features of Pulmonary Tuberculosis with and without HIV infection. J AIDS Clin Res 2012; 3: 188.
[9]
Choi JC, Jarlsberg LG, Grinsdale JA, et al. Reduced sensitivity of the QuantiFERON(®) test in diabetic patients with smear-negative tuberculosis. Int J Tuberc Lung Dis 2015; 19(5): 582-8.
[10]
Bhalla AS, Goyal A, Guleria R, Gupta AK. Chest tuberculosis: Radiological review and imaging recommendations. Indian J Radiol Imaging 2015; 25(3): 213-25.
[11]
Pérez-Guzman C, Torres-Cruz A, Villarreal-Velarde H, Salazar-Lezama MA, Vargas MH. Atypical radiological images of Pulmonary Tuberculosis in 192 diabetic patients: A comparative study. Int J Tuberc Lung Dis 2001; 5(5): 455-61.
[12]
Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 Diabetes Mellitus on the presentation and treatment response of Pulmonary Tuberculosis. Clin Infect Dis 2007; 45(4): 428-35.
[13]
Wang JY, Lee LN, Hsueh PR. Factors changing the manifestation of Pulmonary Tuberculosis. Int J Tuberc Lung Dis 2005; 9(7): 777-83.
[14]
Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among Tuberculosis patients in India. PLoS One 2012; 7(7)e41367
[15]
Jiménez-Corona ME, Cruz-Hervert LP, García-García L, et al. Association of diabetes and tuberculosis: Impact on treatment and post-treatment outcomes. Thorax 2013; 68(3): 214-20.
[16]
Leung CC, Lam TH, Chan WM, et al. Diabetic control and risk of tuberculosis: A cohort study. Am J Epidemiol 2008; 167(12): 1486-94.
[17]
Jain NK, Madan A, Sharma TN, et al. Diabetic tuberculosis: A changing pattern. Lung India 1985; 3: 11-4.
[18]
Morris JT, Seaworth BJ, McAllister CK. Pulmonary tuberculosis in diabetics. Chest 1992; 102(2): 539-41.
[19]
Chang JT, Dou HY, Yen CL, et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: A potential role in the emergence of multidrug-resistance. J Formos Med Assoc 2011; 110(6): 372-81.
[20]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339: b2535.
[21]
World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia 2009. Available from:. http:// www.who.int/diabetes/publications/
[22]
The American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20(7): 1183-97.
[23]
Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. 2013. Available from: http://www.ohri.ca/programs/ clinical_epidemiology/oxford.asp
[24]
Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
[25]
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-58.
[26]
Cavanaugh J, Viney K, Kienene T, et al. Effect of diabetes on tuberculosis presentation and outcomes in Kiribati. Trop Med Int Health 2015; 20(5): 643-9.
[27]
Duangrithi D, Thanachartwet V, Desakorn V, et al. Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand. Int J Clin Pract 2013; 67(11): 1199-209.
[28]
Hongguang C, Min L, Shiwen J, et al. Impact of diabetes on clinical presentation and treatment outcome of pulmonary tuberculosis in Beijing. Epidemiol Infect 2015; 143(1): 150-6.
[29]
Reed GW, Choi H, Lee SY, et al. Impact of diabetes and smoking on mortality in tuberculosis. PLoS One 2013; 8(2)e58044
[30]
Zhang L, Pang Y, Yu X, et al. Risk factors for pulmonary cavitation in tuberculosis patients from China. Emerg Microbes Infect 2016; 5(10)e110
[31]
Alavi SM, Khoshkho MM, Salmanzadeh S, Eghtesad M. Comparison of epidemiological, clinical, laboratory and radiological features of hospitalized diabetic and non-diabetic patients with pulmonary tuberculosis at razi hospital in ahvaz. Jundishapur J Microbiol 2014; 7(9)e12447
[32]
Nakamura A, Hagiwara E, Hamai J, Taguri M, Terauchi Y. Impact of underlying diabetes and presence of lung cavities on treatment outcomes in patients with pulmonary tuberculosis. Diabet Med 2014; 31(6): 707-13.
[33]
Nissapatorn V, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Anuar AK. Tuberculosis in diabetic patients: A clinical perspective. Southeast Asian J Trop Med Public Health 2005; 36(Suppl. 4): 213-20.
[34]
Tatar D, Senol G, Alptekin S, Karakurum C, Aydin M, Coskunol I. Tuberculosis in diabetics: Features in an endemic area. Jpn J Infect Dis 2009; 62(6): 423-7.
[35]
Ralph AP, Ardian M, Wiguna A, et al. A simple, valid, numerical score for grading chest X-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 2010; 65(10): 863-9.
[36]
Falk A, O’Connor B, Pratt PC, et al. Classification of pulmonary tuberculosis. In: Diagnostic Standards and Classification of Tuberculosis. 12th ed. New York: National Tuberculosis and Respiratory Disease Association 1969; pp. 68-76.
[37]
Fiorenza G, Rateni L, Farroni MA, Bogué C, Dlugovitzky DG. TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett 2005; 98(1): 45-8.
[38]
Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 2001; 20(4): 641-54.
[39]
Baghaei P, Marjani M, Javanmard P, Tabarsi P, Masjedi MR. Diabetes mellitus and tuberculosis facts and controversies. J Diabetes Metab Disord 2013; 12(1): 58.
[40]
Magee MJ, Kempker RR, Kipiani M, et al. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia. Int J Tuberc Lung Dis 2015; 19(6): 685-92.
[41]
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab 2012; 16(Suppl. 1): S27-36.
[42]
Padyana M, Bhat RV, Dinesha M, Nawaz A. HIV-Tuberculosis: A study of chest X-ray patterns in relation to CD4 count. N Am J Med Sci 2012; 4(5): 221-5.
[43]
Wilcke JT, Askgaard DS, Nybo Jensen B, Døssing M. Radiographic spectrum of adult pulmonary tuberculosis in a developed country. Respir Med 1998; 92(3): 493-7.
[44]
Song Q, Zhang G, Jiang H, Ren Y, Lu X. Imaging features of pulmonary CT in type 2 diabetic patients with multidrug-resistant tuberculosis. PLoS One 2016; 11(3)e0152507
[45]
Dholakia YN, D’souza DTB, Tolani MP, Chatterjee A, Mistry NF. Chest X-rays and associated clinical parameters in pulmonary tuberculosis cases from the National Tuberculosis Pro-gramme. Infect Dis Rep 2012; 4(1)e10